Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BOSULIF vs BRIGATINIB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BOSULIF vs BRIGATINIB: Safety Overview

Metric BOSULIF BRIGATINIB
Total FAERS Reports 116 3,286
Deaths Reported 6 729
Death Rate 5.2% 22.2%
Hospitalizations 8 912
Average Patient Age 62.6 yrs 61.2 yrs
% Female Patients N/A 57.3%
FDA Approval Date N/A Apr 28, 2017
Manufacturer N/A Takeda Pharmaceuticals America, Inc.
Route N/A ORAL
Marketing Status N/A Prescription